Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joerg Herrmann

Showing results (241-250 of 269) with videos related to

Pageof 27
Sort By:
Frontiers in Cardiovascular Medicine|November 17, 2022
Trigger related outcomes of takotsubo syndrome in a cancer populationAyesha Safdar, Talha Ahmed, Victor Y Liu, et al.
Medicina (Kaunas, Lithuania)|July 27, 2022
Reclassification of Treatment Strategy with Fractional Flow Reserve in Cancer Patients with Coronary Artery DiseaseJin Wan Kim, Tariq J Dayah, Awad Javaid, et al.
JACC. Cardiooncology|May 22, 2024
Artificial Intelligence Electrocardiography to Predict Atrial Fibrillation in Patients With Chronic Lymphocytic LeukemiaGeorgios Christopoulos, Zachi I Attia, Sara J Achenbach, et al.
The Journal of Cardiovascular Aging|July 8, 2022
Cancer treatment-induced NAD+ depletion in premature senescence and late cardiovascular complicationsPriyanka Banerjee, Elizabeth A Olmsted-Davis, Anita Deswal, et al.
CA: a Cancer Journal for Clinicians|September 10, 2020
Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: An International Cardio-Oncology Society (ICOS) statementDaniel Lenihan, Joseph Carver, Charles Porter, et al.
Trends in Cardiovascular Medicine|June 1, 2020
Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) PandemicSarju Ganatra, Sourbha S Dani, Sachin Shah, et al.
Mayo Clinic Proceedings|April 9, 2025
Characterization of Cardiovascular Events and Prognosis in Immune Checkpoint Inhibitor-Related MyocarditisMilagros Pereyra Pietri, Juan M Farina, Isabel G Scalia, et al.
Cancer Medicine|March 27, 2026
Standardizing the Clinical Approach to Cancer Therapy-Related Cardiac Dysfunction: Applying Cardio-Oncology Guidelines as a Practical Tool for Hematology and Oncology ProvidersAbdelrahman Ali, Suparna C Clasen, Anne Blaes, et al.
JACC. Cardiooncology|April 17, 2025
Quality-of-Care Measures for Cardio-Oncology: An IC-OS and ACC Cardio-Oncology Leadership Council PerspectiveVijay U Rao, Anita Deswal, Daniel Lenihan, et al.
European Heart Journal|December 14, 2021
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statementJoerg Herrmann, Daniel Lenihan, Saro Armenian, et al.
Pageof 27

Showing results (241-250 of 269) with videos related to

Sort By:
Pageof 27
Frontiers in Cardiovascular Medicine|November 17, 2022
Trigger related outcomes of takotsubo syndrome in a cancer populationAyesha Safdar, Talha Ahmed, Victor Y Liu, et al.
Medicina (Kaunas, Lithuania)|July 27, 2022
Reclassification of Treatment Strategy with Fractional Flow Reserve in Cancer Patients with Coronary Artery DiseaseJin Wan Kim, Tariq J Dayah, Awad Javaid, et al.
JACC. Cardiooncology|May 22, 2024
Artificial Intelligence Electrocardiography to Predict Atrial Fibrillation in Patients With Chronic Lymphocytic LeukemiaGeorgios Christopoulos, Zachi I Attia, Sara J Achenbach, et al.
The Journal of Cardiovascular Aging|July 8, 2022
Cancer treatment-induced NAD+ depletion in premature senescence and late cardiovascular complicationsPriyanka Banerjee, Elizabeth A Olmsted-Davis, Anita Deswal, et al.
CA: a Cancer Journal for Clinicians|September 10, 2020
Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: An International Cardio-Oncology Society (ICOS) statementDaniel Lenihan, Joseph Carver, Charles Porter, et al.
Trends in Cardiovascular Medicine|June 1, 2020
Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) PandemicSarju Ganatra, Sourbha S Dani, Sachin Shah, et al.
Mayo Clinic Proceedings|April 9, 2025
Characterization of Cardiovascular Events and Prognosis in Immune Checkpoint Inhibitor-Related MyocarditisMilagros Pereyra Pietri, Juan M Farina, Isabel G Scalia, et al.
Cancer Medicine|March 27, 2026
Standardizing the Clinical Approach to Cancer Therapy-Related Cardiac Dysfunction: Applying Cardio-Oncology Guidelines as a Practical Tool for Hematology and Oncology ProvidersAbdelrahman Ali, Suparna C Clasen, Anne Blaes, et al.
JACC. Cardiooncology|April 17, 2025
Quality-of-Care Measures for Cardio-Oncology: An IC-OS and ACC Cardio-Oncology Leadership Council PerspectiveVijay U Rao, Anita Deswal, Daniel Lenihan, et al.
European Heart Journal|December 14, 2021
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statementJoerg Herrmann, Daniel Lenihan, Saro Armenian, et al.
Pageof 27